Systemic hyperthermia masks the neuroprotective effects of MK-801, but not rosiglitazone in Brain Ischaemia

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 3, 2010, Pages 724-729

  Nategh, Mohsen ^a   Shaveisi, Kaveh ^a   Shabanzadeh, Alireza P ^a,b   Sadr, Seyed Sh ^a   Parviz, Mohsen ^a   Ghabaei, Mojdeh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Forensic Medicine Organization of Iran   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; ROSIGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFICACY; HYPERTHERMIA; MALE; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PRODUCTIVITY; RAT; SEIZURE; STROKE; THROMBOEMBOLISM;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; FEVER; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

ANIMALIA; RATTUS;

EID: 77955801613     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00570.x     Document Type: Article

References (41)

1. Danton GH, Dietrich WD. The search for neuroprotective strategies in stroke. Am J Neuroradiol 2004 25 : 181 94.
2. Hussain MS, Shuaib A. Research into neuroprotection must continue but with a different approach. Stroke 2008 39 : 521 2.
3. Albers GW, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 1998 114 : 683S 98S.
4. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G et al. Fever in acute stoke worsens prognosis: a prospective study. Stroke 1995 53 : 72 9.
5. Kiyatkin EA. Brain hyperthermia as physiological and pathological phenomena. Brain Res Rev 2005 50 : 27 56.
6. Noor R, Wang XC, Shuaib A. Effects of hyperthermia on infarct volume in focal embolic model of cerebral ischemia in rats. Neurosci Lett 2003 349 : 130 2.
7. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 1998 29 : 529 34.
8. Meden P, Overgaard K, Pedersen H, Boysen G. The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model. Brain Res 1994 647 : 131 8.
9. Shabanzadeh AP, Shuaib A, Wang CX. Reduction of ischemic brain injury in rats with normothermic and hyperthermic conditions. J Neurosurg 2008 109 : 522 9.
10. Fujiwara T, Okuno A, Yoshioka S, Horikoshi H. Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BLKsJ-dbdb mice. Metabolism 1995 44 : 486 90.
11. Stevenson RW, McPherson RK, Genereux PE, Danbury BH, Kreutter DK. Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia. Metabolism 1991 40 : 1268 74.
12. Stumvoll M, Haring HU. Glitazones: clinical effects and molecular mechanisms. Ann Med 2002 34 : 217 24.
13. Yue T, Chen J, Bao W. In vivo myocardial protection from ischemiareperfusin injury by the peroxisome prolifrator activated receptor- agonist reosiglitazone. Circulation 2002 104 : 2588 94.
14. Sundarajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE. Peroxisome proliferator-activated receptor- ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 2005 130 : 685 96.
15. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, Glass CK. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci 2003 100 : 6712 7.
16. Allahtavakoli M, Shabanzadeh A, Roohbakhsh A, Pourshanazari A. Combination therapy of Rosiglitazone, a peroxisome proliferator-activated receptor- ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats. Basic Clin Pharmacol Toxicol 2007 101 : 309 14.
17. Allahtavakoli M, Shabanzadeh A, Sadr S, Parviz M, Djahanguiri B. Rosiglitazone, a peroxisome proliferator-activated receptor-g ligand, reduces infarction volume and neurological deficits in an embolic model of stroke. Clin Exp Pharmacol Physiol 2006 33 : 1052 8.
18. Besancon E, Guo S, Lok J, Tymianski M, Lo EH. Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 2008 25 (5 268 75.
19. Wang CX, Yang Y, Yang T, Shuaib A. A focal embolic model of cerebral ischemia in rats: introduction and evaluation. Brain Res Protoc 2001 7 : 115 20.
20. Yang Y, Shuaib A, Li Q. Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method. J Neurosci Methods 1998 84 : 9 16.
21. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion evaluation of the model and development of a neurologic examination. Stroke 1986 17 : 472 6.
22. Racine RJ. Modification of seizure activity by electrical stimulation II Motor seizure. Electroencephalogr Clin Neurophysiol 1972 32 : 281 94.
23. Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia Int J Hyperthermia 2003 19 : 267 94.
24. Coimbra C, Boris-Moller F, Drake M, Wicloch T. Diminished neuronal damage in the rat brain by late treatment with antipyretic drug dipyrone or cooling following cerebral ischemia. Acta Neuropathol (Berl) 1996 92 : 447 53.
25. Dietrich WD, Busto R, Valdes I, Loor Y. Effects of normothermic versus mild hyperthermic forebrain ischemia in rats. Stroke 1990 21 : 1318 25.
26. Chen H, Chopp M, Welch KM. Effect of mild hyperthermia on the ischemic infarct volume after middle cerebral artery occlusion in the rat. Neurology 1991 41 : 1133 5.
27. Globus MY, Busto R, Lin B, Schnippering H, Ginsberg MD. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation J Neurochem 1995 65 : 1250 6.
28. Sharma HS, Alm P, Westman J. Nitric oxide and carbon monoxide in the pathophysiology of brain functions in heat stress. Prog Brain Res 1998 115 : 297 333.
29. Noor R, Wang XC, Shuaib A. Hyperthermia masks the neuroprotective effects of tissue plasminogen activator. Stroke 2005 36 : 665 9.
30. Bordet R, Ouk T, Petrault O, Gelé P, Gautier S, Laprais M et al. PPAR a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 2006 34 : 1341 6.
31. Aoun P, Watson DG, Simpkins JW. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. Eur J Pharmacol 2003 472 : 65 71.
32. Heneka MT, Klockgether T, Feinstein DL. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci 2000 20 : 6862 7.
33. Sundarajan S, Landreth GE. Antiinflammatory properties of PPAR agonists following ischemia. Drug News Perspect 2004 17 : 229 35.
34. Corbett D, Evans S, Thomas C, Wang D, Jonas RA. MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res 1990 514 : 300 4.
35. Buchan A, Pulsinelli WA. Hypothermia but not the N-methyl-d-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 1990 10 : 311 6.
36. Alkan T, Kahveci N, Buyukuysal L, Korfali E, Ozluk K. Neuroprotective effects of MK 801 and hypothermia used alone and in combination in hypoxic-ischemic brain injury in neonatal rats. Arch Physiol Biochem 2001 109 : 135 44.
37. Gilland E, Hagberg H. Is MK-801 neuroprotection mediated by systemic hypothermia in the immature rat? Neuroreport 1997 8 : 1603 5.
38. Green EJ, Pazos AJ, Dietrich WD, McCabe PM, Schneiderman N, Lin B et al. Combined postischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats. Brain Res 1995 8 : 702.
39. Hattori H, Wasterlain CG. Hypothermia does not explain MK-801 neuroprotection in a rat model of neonatal hypoxic-ischemic encephalopathy. Neurology. 1991 41 2 (Pt 1) 330.
40. Gill R, Woodruff GN. The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia. Eur J Pharmacol 1990 176 : 143 9.
41. Harada S, Fujita W, Shichi K, Tokuyama S. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 2009 1279 : 174 81.